These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36413004)

  • 21. Irreversible electroporation for colorectal cancer liver metastasis: a review.
    Koethe Y; Wilson N; Narayanan G
    Int J Hyperthermia; 2022; 39(1):682-687. PubMed ID: 35469520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irreversible Electroporation for Colorectal Liver Metastases.
    Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery.
    Shiina S; Sato K; Tateishi R; Shimizu M; Ohama H; Hatanaka T; Takawa M; Nagamatsu H; Imai Y
    Can J Gastroenterol Hepatol; 2018; 2018():4756147. PubMed ID: 29974040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What's New in Percutaneous Ablative Strategies for Hepatocellular Carcinoma and Colorectal Hepatic Metastases? 2020 Update.
    Arellano RS
    Curr Oncol Rep; 2020 Jul; 22(10):105. PubMed ID: 32725433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Irreversible electroporation: a new form of image-guided tumour ablation].
    Scheffer H; Nielsen K; van Tilborg A; Vieveen JM; van den Tol MP; Meijerink MR
    Ned Tijdschr Geneeskd; 2014; 158():A7176. PubMed ID: 24518847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.
    Sutter O; Calvo J; N'Kontchou G; Nault JC; Ourabia R; Nahon P; Ganne-Carrié N; Bourcier V; Zentar N; Bouhafs F; Sellier N; Diallo A; Seror O
    Radiology; 2017 Sep; 284(3):877-886. PubMed ID: 28453431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Needle tract seeding following percutaneous irreversible electroporation for hepatocellular carcinoma.
    Onafowokan OO; de Liguori Carino N
    BMJ Case Rep; 2022 Oct; 15(10):. PubMed ID: 36223977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulse Parameters and Thresholds for (ir)Reversible Electroporation on Hepatocellular Carcinoma Cells
    Lindelauf KHK; Baragona M; Baumann M; Maessen RTH; Ritter A
    Technol Cancer Res Treat; 2023; 22():15330338221136694. PubMed ID: 36600679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
    Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z
    BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on irreversible electroporation of liver tumours.
    Yeung ES; Chung MW; Wong K; Wong CY; So EC; Chan AC
    Hong Kong Med J; 2014 Aug; 20(4):313-6. PubMed ID: 24914075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal liver metastases: making the unresectable resectable using irreversible electroporation for microscopic positive margins - a case report.
    Schoellhammer HF; Goldner B; Merchant SJ; Kessler J; Fong Y; Gagandeep S
    BMC Cancer; 2015 Apr; 15():271. PubMed ID: 25886376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technology of irreversible electroporation and review of its clinical data on liver cancers.
    Cohen EI; Field D; Lynskey GE; Kim AY
    Expert Rev Med Devices; 2018 Feb; 15(2):99-106. PubMed ID: 29307242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local-regional treatment of hepatocellular carcinoma.
    Lencioni R; Crocetti L
    Radiology; 2012 Jan; 262(1):43-58. PubMed ID: 22190656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irreversible electroporation for the ablation of liver tumors: are we there yet?
    Charpentier KP
    Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Image-guided ablation for hepatocellular carcinoma.
    Lencioni R; Crocetti L
    Recent Results Cancer Res; 2013; 190():181-94. PubMed ID: 22941021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
    PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Irreversible electroporation: local, non-thermal, ablation therapy of malignant tumours].
    Janík V; Skrabalová D; Gürlich R; Málek J
    Cas Lek Cesk; 2013; 152(2):67-75. PubMed ID: 23641678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations.
    Nault JC; Sutter O; Nahon P; Ganne-Carrié N; Séror O
    J Hepatol; 2018 Apr; 68(4):783-797. PubMed ID: 29031662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.